TG United Recalls ZoDen DM Drops Due to Underdosing
TG United, Inc. is recalling ZoDen DM Drops because the product is underdosed or has an incorrect dosage regime.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the rubric specifies that FDA Class II recalls with significant injury/property-damage reports or structural defects are Severe. While no injuries are explicitly reported, the 'incorrect dosage regime' for a pharmaceutical product represents a significant risk of harm, aligning with the Severe classification for Class II drug recalls involving dosage errors.
Plain-English summary
TG United, Inc. is voluntarily recalling 39,801 bottles of ZoDen DM Drops, an over-the-counter antihistamine, cough suppressant, and decongestant. The recall is being conducted because the products are underdosed or have an incorrect dosage regime, which constitutes a deviation from Current Good Manufacturing Practices (CGMP).
The affected product is the 1 fl oz. (30 mL) bottle, manufactured for Trigen Laboratories. The recall includes specific lots: Lot# 11EQ009 (Exp 04/13), Lot# 12AQ004 (Exp. 12/13), and Lot# 12KQ001 (Exp. 09/14).
The recalled product was distributed in Florida, Mississippi, South Carolina, Louisiana, and Texas. Consumers who have purchased this product should stop using it and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- ZoDen DM Drops, Antihistamine,Cough Suppressant, Decongestant, , 1 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872, NDC 13811-0080-30
- Manufacturer
- TG United, Inc.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot# 11EQ009 Exp 04/13
- Lot# 12AQ004 Exp. 12/13
- Lot# 12KQ001 Exp. 09/14.
Distribution
Part of a larger recall action
This product is one of 44 recalled by TG United, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 44 products in this recall →Related recalls
Same manufacturer · TG United, Inc.
See all →- SevereTG United Recalls Trigofen DM Drops Due to Underdosing
FDA (Drugs) · 2013-06-12
- SevereTG United Recalls Underdosed AMBI Antihistamine Nasal Decongestant Syrup
FDA (Drugs) · 2013-06-12
- ModerateTG United Recalls Underdosed AMBI Cough Suppressant and Expectorant
FDA (Drugs) · 2013-06-12
- SevereTG United Recalls Z-Dex Syrup Due to Underdosing and Incorrect Dosage
FDA (Drugs) · 2013-06-12
- ModerateTG United Recalls CPM PSE Drops Due to CGMP Deviations
FDA (Drugs) · 2013-06-12
Same hazard · underdosing
See all →- SevereBD Texium Closed System Drug Transfer Devices May Leak at Connector
FDA (Devices) · 2025-06-18
- HighBD TEXIUM Closed Male Luer Devices Recalled for Leaking Interface Risk
FDA (Devices) · 2025-06-18
- HighAlaris Pump Infusion Sets may leak at male luer connections
FDA (Devices) · 2025-06-18
- HighBD TEXIUM Closed Male Luer Drug Transfer Device Recall
FDA (Devices) · 2025-06-18
- HighBD Texium Needle-Free Syringe Recalled for Potential Leakage at Luer Interface
FDA (Devices) · 2025-06-18
Similar recalls
- ModerateDoloDent Maximum Strength Toothache Drops Recalled for cGMP Deviations
FDA (Drugs) · 2025-04-30
- ModerateAllergan Recalls 72 Bottles of Combigan Eye Drops for cGMP Deviations
FDA (Drugs) · 2019-04-03
- ModeratePD-Rx Recalls Clonidine Hydrochloride Tablets Due to cGMP Deviations
FDA (Drugs) · 2016-01-06
- LowOsmotica Recalls Subpotent Methylphenidate Hydrochloride Extended-Release Tablets
FDA (Drugs) · 2017-12-27
- ModerateMutual Pharmaceutical Recalls Clonidine Hydrochloride Tablets Due to cGMP Deviations
FDA (Drugs) · 2015-08-05
- HighTizanidine 4mg Tablets Recalled for Contamination with 2mg Tablets
FDA (Drugs) · 2024-01-17